Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06538233 · ClinicalTrials.gov registry record · Phase 2
Pain After Buffered Vs Non Buffered Articaine
A Phase 2 study of Pain, sponsored by Cleveland Dental Institute.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT06538233: Recruiting Phase 2 study of Pain, sponsored by Cleveland Dental Institute.
NCT06538233 is a Phase 2 study of Pain that is actively recruiting participants, run by Cleveland Dental Institute. The registered enrollment target is 108 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06538233, a Phase 2 study of Pain, is actively recruiting participants, sponsored by Cleveland Dental Institute.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
Pain after buffered versus non buffered articaine.
Conditions Studied
Interventions
- DRUG Buffered articaine
- DRUG Non buffered articaine
Study Locations (1)
Ohio
- Clevland Dental Institute - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2025-01-31 |
| Phase | Phase 2 |
What NCT06538233 shows while recruiting
NCT06538233 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Buffered articaine is the first listed.
NCT06538233 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06538233 about?
NCT06538233 is a clinical study titled "Pain After Buffered Vs Non Buffered Articaine". Pain after buffered versus non buffered articaine.
What is the current status of trial NCT06538233?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2024-01-01. Estimated completion is 2025-01-31.
What conditions does trial NCT06538233 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT06538233?
The interventions under investigation include: Buffered articaine (DRUG), Non buffered articaine (DRUG).
Who is sponsoring clinical trial NCT06538233?
This trial is sponsored by Cleveland Dental Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06538233 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06538233's enrollment target sits among peer trials
108 155th of 374 higher than 220 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Neural Correlates of Hypoalgesia Driven by Observation
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI